SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

AstraZeneca Receives FDA Priority Review for Sonesitatug Vedotin

The FDA is expected to decide on the application in Q2 2027.

AZN

Related stories